The story has been updated to clarify that the New York State approval includes the regular Panorama panel and 22q11.2 deletion syndrome.

NEW YORK (GenomeWeb) – Prenatal testing firm Natera today said that it has received conditional approval from New York State to offer the expanded Panorama non-invasive prenatal test to residents in the state.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.